Designing chemically modified oligonucleotides for targeted gene silencing

Area of Science:

• Molecular Biology
• Medicinal Chemistry
• Genetics

Background:

• Oligonucleotides (ONs) and their modified analogs are widely used in molecular biology to regulate gene expression.
• These molecules are increasingly investigated for therapeutic applications, showing promise for future treatments.

Purpose of the Study:

• To review key classes of gene-regulating ONs, including antisense ONs (AONs), small interfering RNAs (siRNAs), and microRNA-targeting ONs (anti-miRNAs).
• To provide a detailed overview of chemical modification strategies for optimizing ON biological activity and therapeutic potential.
• To clarify the biological pathways, chemical properties, benefits, and limitations of various oligonucleotide analogs in nucleic acid research.

Main Methods:

• Literature review of current research on oligonucleotide classes and chemical modifications.
• Analysis of biological pathways, chemical properties, and therapeutic applications of ONs.
• Synthesis of information on benefits and limitations of oligonucleotide analogs.

Main Results:

• Discussion of AONs, siRNAs, and anti-miRNAs as primary tools for gene expression control.
• Detailed account of chemical modification strategies enhancing ON efficacy and therapeutic viability.
• Clarification of the mechanisms, advantages, and drawbacks associated with different ON analogs.

Conclusions:

• Oligonucleotide-based therapies hold significant therapeutic potential.
• Chemical modifications are crucial for optimizing the performance of ONs in biological systems and clinical settings.
• Understanding the properties and limitations of ON analogs is essential for advancing nucleic acid-based research and medicine.